•  
  •  
  •  
  •  

2026-08-11 09:56:18

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra

Keywords Selected:  UnichemLaboratories

Stock Report

  • Unichem Pharmaceuticals (USA) Issues Voluntary Recall of Buspirone Hydrochloride Tablets
  • Unichem Laboratories Ltd pays fine of Euro 16,753,873.41 to European Commission
  • Unichem Laboratories Ltd receives EIR from USFDA classifying Roha API facility as VAI
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • Unichem Laboratories Ltd receives 4 observations from USFDA for Pithampur API facility
  • Unichem Laboratories Ltd gets 5 observations from USFDA for Goa formulation facility
  • Unichem Laboratories Ltd consolidated Q3 FY24 PAT rises to Rs. 83.99 crores
  • Unichem Laboratories Ltd receives ANDA approval for Doxazosin Tablets
  • Unichem Laboratories Ltd receives ANDA approval for Prasugrel Tablets
  • Unichem Laboratories Ltd Q1FY24 consolidated loss at Rs. 66.83 lakhs
  • Unichem Laboratories Ltd Q4 FY2023 consolidated loss at Rs. 44.26 crores
  • Ipca Laboratories Ltd to acquire majority stake in Unichem Laboratories Ltd
  • Unichem Laboratories Ltd appoints Ms. Priti Puri as additional independent director
  • Unichem Laboratories Ltd receives ANDA approval for Ranolazine Extended-Release Tablets
  • Unichem Laboratories Ltd consolidated Q3FY23 loss at Rs. 63.92 crores
  • Unichem Laboratories receives ANDA approval for Extended Phenytoin Sodium Capsules
  • Unichem Laboratories Ltd sells 1st tranche of stake in Optimus for Rs. 270.98 crores
  • ICRA downgrades Unichem Laboratories' rating for Rs. 176 crs bank facilities
  • Unichem Laboratories receives ANDA approval from USFDA for Carbamazepine Tablets USP
  • Unichem Laboratories receives ANDA Approval for Quetiapine Extended-Release Tablets
  • Unichem Laboratories receives ANDA approval for Labetalol Hydrochloride Tablets
  • Unichem Laboratories Ltd Q1 FY2023 consolidated loss at Rs. 23.36 crores
  • Unichem Laboratories Ltd reports surge in Q4FY22 consolidated PAT to Rs. 71.47 crores
  • Unichem Laboratories Ltd Board recommends Dividend of Rs. 4

Latest Post

  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025